PROK
ProKidneyCNasdaq / Pharmaceuticals, Biotechnology & Life Sciences
Last Price
At close
2026-07-20
+
Peers tracked
10
U.S. public peers
Grade Position
In line
vs peer average
PROK vs peer average
61/100
PROK vs. peer average (C vs. D)
Grade spread
B 2 · C 2 · D 3 · F 3
Graded peers loaded
Coverage
10 graded
100% of tracked
Peer overview
OVID is the first available peer comparator.
Loose small-cap clinical-stage biotech comp with similarly binary value drivers and external-financing sensitivity, though not a kidney-cell-therapy peer.
✓Peer source comes from the stored AI memo or peer model
✓Grades and factor rows use RankAlpha API data when available
✓Missing peer scores remain blank instead of being estimated
✓Side-by-side comparison keeps the data contract visible
PROK
ProKidney
OVID
Ovid Therapeutics
Grade
C
B
Momentum
47
93
Value
41
41
Sentiment
66
51
Setup Bias
Net —
-
Market Cap
-
-
Posture
Mixed
Constructive
Grade position vs OVID
PROK / OVID
Grade Position
In line
PROK vs. peer average (C vs. D)
61/100
Momentum
47
OVIDValue
41
PROKSentiment
66
PROKRotation landscape
Peers ranked by the order returned from the peer source, with grades from the API.
Rank
Ticker
Company
Grade
Grade score
vs PROK
OVID is the first peer returned for this comparison set.